Skip to main content

Peer Review reports

From: Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol

Original Submission
9 Jun 2017 Submitted Original manuscript
2 Aug 2017 Author responded Author comments - Sheeba Thomas
Resubmission - Version 2
2 Aug 2017 Submitted Manuscript version 2
14 Nov 2017 Author responded Author comments - Sheeba Thomas
Resubmission - Version 3
14 Nov 2017 Submitted Manuscript version 3
Publishing
5 Feb 2018 Editorially accepted
13 Feb 2018 Article published 10.1186/s12885-018-4094-2

You can find further information about peer review here.

Back to article page
\